
Navigating the Future of Environmental, Health & Safety in Biopharma
As the biopharma industry evolves with rapid advancements in drug development, manufacturing, and research, EHS leaders are tasked with safeguarding employee health, maintaining a culture of safety, and addressing environmental concerns. Navigating these challenges while meeting sustainability goals and mitigating risks has become essential for operational success. EHS professionals must continuously adapt to this dynamic landscape to protect their most valuable asset: their workforce.
The 2nd EHS for Biopharma East Summit is an essential event for EHS professionals working in the biopharma industry, focused on overcoming the sector's unique regulatory and operational challenges. With over 80+ attendees, this summit will provide valuable insights on navigating evolving regulations, optimizing safety protocols, and enhancing environmental stewardship. Whether your goal is to strengthen safety culture, reduce incidents, or achieve sustainability targets, the summit offers the tools, knowledge, and networking opportunities necessary to elevate EHS practices.
Gain Points Towards Your Recertification
By attending this safety initiative, you could earn points towards your recertification, meaning you can earn while you learn.
BGC® Diplomates can earn up to 15 technical contact hours (or 2.5 CM points) for this event. See http://www.GoBGC.org/practitioners_CIH_educationalevents for more information.
BCSP Diplomates can earn up to 15 technical contact hours (1.5 points) for this event
This event has also been approved by ABSA International for 0.125 CM points toward RBP/CBSP recertification



Previously Attending Companies Include:


"This conference was outstanding. I particularly enjoyed the biopharmaceuticals industry focus number and diversity of attendees, all the topics and speakers.”
- Global Head of Environment, Health, and Safety & Sustainability, Ultragenyx Pharmaceutical

"It was great to bring peers together to discuss the key issues facing the industry and profession, as well as to hear about the strategies and approaches each organization is taking to address these challenges. The well-planned agenda, which included a diverse range of organizations—from large global companies to small, local ones—fostered engaging discussions and created an inclusive atmosphere."
- Head of Safety, Health, Environment & Global Operations, AstraZeneca